InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Plooster Matthew R, Director. Insider active across 1 companies, notably Kempharm, INC. Aggregated, 3 reports have been published. Total volume traded: €3k. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€3,278695 shares@ €4.7178.1% of flow
Common Stock
SEC:0001437749-22-012945:0·
Ideal exit: 12 Feb 2023 (T+270)
€18,6232,500 shares@ €7.4491100.0% of flow
Common Stock
SEC:0001437749-21-027630·
€18,6232,500 shares@ €7.449146.0% of flow
Common Stock
SEC:0001437749-21-027630:0·
3 of 3 declarations
About Plooster Matthew R
Matthew R. Plooster is a Director at KEMPHARM, INC. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of KEMPHARM.
